Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Validation of the IPF-specific version of St. George's Respiratory Questionnaire

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk factors for diagnostic delay in idiopathic pulmonary fibrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prevalence and course of disease after lung resection in primary ciliary dyskinesia: a cohort & nested case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Interstitial lung abnormalities in people with HIV infection and uninfected controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. ERS and tobacco harm reduction

    Research output: Contribution to journalEditorialResearch

  3. β2-Adrenergic genotypes and risk of severe exacerbations in COPD: a prospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Chronic obstructive pulmonary disease (COPD) is a multifaceted condition that cannot be fully described by the severity of airway obstruction. The limitations of spirometry and clinical history have prompted researchers to investigate a multitude of surrogate biomarkers of disease for the assessment of patients, prediction of risk, and guidance of treatment. The aim of this review is to provide a comprehensive summary of observations for a selection of recently investigated pulmonary inflammatory biomarkers (Surfactant protein D (SP-D), Club cell protein 16 (CC-16), and Pulmonary and activation-regulated chemokine (PARC/CCL-18)) and systemic inflammatory biomarkers (C-reactive protein (CRP) and fibrinogen) with COPD. The relevance of these biomarkers for COPD is discussed in terms of their biological plausibility, their independent association to disease, their hard clinical outcomes, their modification by interventions, and whether changes in clinical outcomes are reflected by changes in the biomarker.

Original languageEnglish
JournalRespiratory Research
Volume15
Issue number1
Pages (from-to)147
ISSN1465-9921
DOIs
Publication statusPublished - 25 Nov 2014

ID: 45000119